Pharmalot... Pharmalittle... Good Morning

Hello, everyone, and how are you today? We are quite busy this morning as we scramble to play catch up after dining with interesting sources last night. The routine never stops. And so, to cope, we are reaching for that treasured cup of stimulation and invite you to do the same. After all, there is much to be done. On that note, here is a new batch of tidibits. We hope your day goes well and do stay in touch... How Cancer Drugs Can Skip Randomized Trials (Reuters) Merck Halts Sale Of Combo Pill For Diabetes And Cholesterol (Philadelphia Inquirer) Sanofi Cholesterol Drug Is Touted As A Potential Blockbuster (Reuters) Pfizer Plans To Close Plant In Australia (Global Times) Japanese Health Official Is 'Shocked' By Diovan Data Scandal (Wall Street Journal) J&J Has Doxil Shortage Over Contractor Problems (MoneyControl) FDA Boosts Warnings On Rituxan And Arezzera Over Hepatitis B (MedPage Today) Purdue Pharma To Create 100 Jobs At North Carolina Factory (The News & Observer) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs